Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
Canada
Americas
Clear all
Type of publications
NITAG documentation
(105)
Scientific publications
(3)
Systematic reviews (SYSVAC)
(8)
Topics
Regions
Americas
(116)
Countries
Canada
(116)
Argentina
(30)
Bolivia
(3)
Brazil
(4)
Chile
(66)
Colombia
(1)
Costa Rica
(1)
Honduras
(14)
Mexico
(1)
Nicaragua
(1)
Peru
(2)
United States of America
(430)
Uruguay
(2)
Diseases
COVID-19
(41)
Diphtheria
(2)
Hepatitis B
(1)
Herpes zoster
(1)
Human papillomavirus (HPV)
(4)
Influenza
(20)
Measles
(1)
Meningococcal disease
(7)
Mpox // Monkeypox
(2)
Mumps
(1)
Pertussis
(2)
Pneumococcal disease
(7)
Rabies
(1)
Rotavirus
(2)
Rubella
(1)
Tuberculosis
(1)
Varicella
(4)
Publication date
2024
(1)
2023
(11)
2022
(21)
2021
(19)
2020
(10)
2019
(4)
2018
(5)
2017
(4)
2016
(3)
2015
(6)
2014
(8)
2013
(1)
2010
(11)
2009
(4)
2008
(5)
2006
(1)
2005
(1)
Target population
Adolescents
(2)
Adults
(5)
All age groups
(6)
Children
(1)
Healthcare workers
(3)
Newborn
(1)
Older adults
(5)
Parents/caregivers
(1)
Pregnant women
(2)
Available to download in languages
English (EN)
(91)
French (FR)
(38)
116 results found
2022
∙
NACI
Process for incorporating economic evidence into federal vaccine recommendations: National Advisory Committee on Immunization (NACI)
2022
∙
Public Health Agency of Canada
Updated guidance on COVID-19 vaccines for individuals who are pregnant or breastfeeding
2022
∙
NACI
Initial guidance on a second booster dose of COVID-19 vaccines in Canada
2022
∙
NACI
Interim guidance on planning considerations for a fall 2022 COVID-19 vaccine booster program in Canada
2022
∙
NACI, Public Health Agency of Canada
NACI Rapid Response - Interim guidance on the use of Imvamune® in the context of monkeypox outbreaks in Canada
2022
∙
NACI
NACI Recommendations on the use of Medicago COVID-19 vaccine (Covifenz)
2022
∙
NACI
NACI Recommendations on the use of Moderna Spikevax COVID-19 vaccine in children 6 to 11 years of age
2022
∙
NACI
NACI Recommendations on the use of Novavax Nuvaxovid COVID-19 vaccine
2022
∙
NACI
Recommendations on the use of Moderna Spikevax COVID-19 vaccine in children 6 months to 5 years of age
2022
∙
NACI, Public Health Agency of Canada
Recommended use of palivizumab to reduce complications of respiratory syncytial virus infection in infants
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register